Source: Reimbursement Intelligence

CHATHAM, NEW JERSEY – This week’s front page headlines read: "Pricey Drugs Put Squeeze on Doctors" and "Costly Cancer Drug Offers Hope, but Also a Dilemma" in The Wall Street Journal and The New York Times, respectively.

Cancer therapies are no longer affordable for patients nor the physicians who prescribe them. According to The Wall Street Journal, "American doctors rarely used to let costs factor into their treatment decisions. But rising prices […] are dramatically changing that ethos in the field of oncology." It is for this reason, that reimbursement plays such a critical part in evaluating oncology development.

To view the complete article, please click here.